- Reaction score
- 107
He is easily NW2. If he's NW1 I must be NW0 and I know that ain't true lol
He does have good density though maybe he just has a mature hairline or just got on finasteride early.
Bayer Prolactin Receptor Antibody For Male And Female Pattern Hair Loss
- Thread starter Ollie
- Start date
He is easily NW2. If he's NW1 I must be NW0 and I know that ain't true lol
He does have good density though maybe he just has a mature hairline or just got on finasteride early.
- Reaction score
- 1,335
"Don't vote. It just encourages the bastards."
- Reaction score
- 207
are you voting for the Z an is norwoo 6 of peace?
hey guys on our China HMI WeChat website： 近日，Hope Medicine Inc.（和其瑞医药）（以下简称“和其瑞”），一家科学驱动的临床阶段创新生物制药公司，宣布其拥有全球权益的首创单抗新药HMI-115，继2021年获得美国食品药品监督管理局（FDA）批准开展治疗子宫内膜异位症二期临床试验（IND）后，其用于治疗雄激素脱发（Androgenetic Alopecia）的二期临床试验申请（IND），也于近日获得美国FDA同意。 Recently, Hope Medicine Inc. (Heqi Rui Medicine) (hereinafter referred to as "He Qi Rui"), a science-driven clinical-stage innovative biopharmaceutical company, announced that it has global rights to the first-in-class new monoclonal antibody drug HMI-115, following 2021. After obtaining approval from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial (IND) for the treatment of endometriosis, its application for a Phase II clinical trial (IND) for the treatment of androgenetic alopecia (Androgenetic Alopecia) was also announced in Recently approved by the US FDA. That is so excited！！
“Phase II clinical trial (IND) for the treatment of androgenetic alopecia (Androgenetic Alopecia) was also announced in Recently approved by the US FDA.”
Great news!
Hope Medicine Inc. ('HopeMed'), a clinical stage innovative biopharmaceutical company, has recently announced that U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for phase II study to evaluate HMI-115, a first-in-class monoclonal antibody drug in treating androgen alopecia
www.prnewswire.com
Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in Androgen Alopecia
/PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative biopharmaceutical company, has recently announced that U.S. Food and Drug...
www.prnewswire.com
- Reaction score
- 614
Like you wouldn't be willing to fly to any state every two weeks to take part
Lol you know it. The closer the better
- Reaction score
- 107
Are you actually planning on taking part in these trials? Do you have to pay or how exactly does it work?
Other companies make promises, HMI makes clinical trials.
Yes. You have to go to the specified location every two weeks to receive an injection. You don't pay anything. You can't be on any other treatments, and you will likely need to have severe hair loss. Typically you have to be off other treatments for 6 months prior to the trial
Last edited:
The trials will probably be studying crown areas rather than frontal/hairline. They normally do that because crown loss is more consistent (read: easier to study). Hairlines & temples can vary wildly from one man to the next, both the rate of loss and the ease of reversal.
- Reaction score
- 1,242
Me the day they open the center for the trial somewhere.
Attachments
- Reaction score
- 984
Where Are you from and would you Go to Australia or USA For the trial?
- Reaction score
- 107
Oh dang I wont really wanna get off finasteride tbh
Even though I believe this is a potential cure I don’t wanna risk it. Guess I’m paying full price lol
Plus my hair loss isn’t severe anyways
Almost doubling hair density is really nothing for an area that is already bald. If you go from 4 hairs/cm2 to 8 hairs/cm2 in an area that you used to have 100+ hairs/cm2 it doesn’t mean anything. So I hope that info is not accurate (and according to the pictorial results of those macaques I think the density virtually got much better)